BridgeBio Oncology Q3 EPS $(0.43) Beats $(0.69) Estimate
Benzinga Newsdesk 6 hours ago
NewsEarningsEarnings Beats
BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.69) by 37.68 percent. This is a 58.25 percent increase over losses of $(1.03) per share
BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.69) by 37.68 percent. This is a 58.25 percent increase over losses of $(1.03) per share from the same period last year.